Shares of Novo Nordisk (NYSE: NVO) fell on Monday, finishing down 5.6%. The drop comes as the S&P 500 and the Nasdaq ...

Discover why Centrus’ cash strength, rising demand, and unique US enrichment position drive a speculative buy outlook.

ThredUp Inc. is rated a Buy with strong year-to-date gains and accelerating order growth. Learn more about TDUP stock here.

The Dow Jones index and the Nasdaq rise on the stock market today. Tesla jumps amid an AI boast by Elon Musk. Some health ...

Earnings reports can swing fortunes overnight, and we saw a study in contrasts last week Nvidia (NASDAQ:NVDA) unveiled its ...

HighPeak Energy stock is set to benefit from restructured leadership and operations and aims for stronger cash flow. Click ...

Iovance Biotherapeutics management is shifting focus from patient infusions to revenue as the primary performance metric.

Novo Nordisk's stock fell after semaglutide's Alzheimer's news. Click here for how strong fundamentals and growth catalysts ...

The Disney Destiny embarked on its maiden voyage out of Florida over the weekend. It's the seventh vessel in the ...

Novo Nordisk stock share price today fell after the company announced that semaglutide, used in Ozempic and Wegovy, failed to ...